Filing Details
- Accession Number:
- 0001138723-11-000049
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-09-19 20:57:59
- Reporting Period:
- 2011-09-15
- Filing Date:
- 2011-09-19
- Accepted Time:
- 2011-09-19 20:57:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138723 | Accuray Inc | ARAY | Surgical & Medical Instruments & Apparatus (3841) | 770268932 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1387517 | Chris Raanes | 1310 Chesapeake Terrace Sunnyvale CA 94089 | Svp Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-09-15 | 2,000 | $2.50 | 119,646 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-09-15 | 2,000 | $4.75 | 117,646 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2011-09-15 | 7,000 | $0.75 | 124,646 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-09-15 | 7,000 | $4.78 | 117,646 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-09-15 | 7,000 | $0.00 | 7,000 | $0.75 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2011-09-15 | 2,000 | $0.00 | 2,000 | $2.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
88,000 | 2012-12-02 | No | 4 | M | Direct | |
17,250 | 2014-08-10 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price. The shares were sold at prices ranging from $4.75 to $4.76 per share. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average sale price. The shares were sold at prices ranging from $4.75 to $4.81 per share. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- The options are exercisable as they vest. A total of 25% of the entire number of shares subject to this stock option becomes vested and fully exercisable on the first anniversary of the vesting commencement date and the remaining shares subject to this stock option vest and become exercisable in equal monthly installments, ratably over the following 36 months.
- These options are exercisable as they vest. The shares subject to this stock option become vested and fully exercisable in equal monthly installments, ratably over a period of 48-months.